Review
Aug 2026
KRAS G12C-mutated Metastatic Colorectal Cancer: Current Therapeutic Strategies and Future Directions
The biologic rationale, current clinical evidence, practical guideline-based positioning, practical guideline-based positioning, toxicity management considerations, resistance mechanisms, and emerging therapeutic strategies for KRAS G12C-mutated mCRC are summarized.
T. Sagawa, H. Nagashima, K. Fujikawa
· Journal of Gastrointestinal... · 0 citations